Predictive Oncology Inc. (NASDAQ: POAI) Continues to Innovate to Improve Outcomes for Cancer Patients
POAI is leveraging the potential of AI and smart tumor profiling to predict tumor drug response TumorGenesis is developing innovative…
POAI is leveraging the potential of AI and smart tumor profiling to predict tumor drug response TumorGenesis is developing innovative…
More than 125 direct-selling experts met with members of Congress to encourage support of the Preserving the Direct Seller Independence…
Lexaria Bioscience is helping to revolutionize efforts to provide common drug substances in an ingestible method that avoids unhealthy practices…
Supreme Cannabis Company (TSX: FIRE) (OTCQX: SPRWF) (FRA: 53S1) today announced that its premium wellness brand and a multi-licensed processor…
INmune Bio (NASDAQ: INMB), a clinical-stage immunology company focused on developing treatments that harness the patient’s innate immune system to…
B2Digital (OTC: BTDG) today announced that its innovative B2 Social Media Network (“B2SN”) exceeded 3.9 million social media connections in…
Nightfood Holdings Inc. (OTCQB: NGTF), the innovative company addressing America’s $50 billion nighttime snacking problem, today announced that sleep-friendly Nightfood…
Data analysis enables increased effectiveness, reduced costs and better outcomes for both surgeons and patients ORHub recently announced a stay…
Global innovator in drug delivery platforms Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) today provided an update on the ongoing…
Chemistree Technology (CSE: CHM) (OTCQB: CHMJF) on Monday announced termination of the proposed investment into The Physician's Choice CBD ("PCCBD")…